Micardis HCT Related Published Studies
Well-designed clinical trials related to Micardis HCT (Telmisartan / Hydrochlorothiazide)
Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension. [2009.01]
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies. [2008.06]
Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial. [2008.02]
Nilotinib. [2008]
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. [2006.03]
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial. [2005.11]
Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension. [2005.07]
Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation. [2005.05]
Angiotensin II receptor antagonist telmisartan in isolated systolic hypertension (ARAMIS) study: efficacy and safety of telmisartan 20, 40 or 80 mg versus hydrochlorothiazide 12.5 mg or placebo. [2004.05]
Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study. [2004.01]
Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design. [2003.12]
Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study. [2003.08]
Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension. [2003.05]
Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension. [2002.03]
Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications. [2002]
Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy. [2001.11]
Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. [2001.06]
Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study. [2001.01]
Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension. [2001.01]
Multiple-dose pharmacokinetics of telmisartan and of hydrochlorothiazide following concurrent administration in healthy subjects. [2000.12]
Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. [1999.05]
The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension. [1999.04]
Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group. [1999.02]
Well-designed clinical trials possibly related to Micardis HCT (Telmisartan / Hydrochlorothiazide)
Results of increasing doses of hydrochlorothiazide in combination with an angiotensin receptor blocker in patients with uncontrolled hypertension. [2008.08]
Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. [2004.09]
Different effect of antihypertensive drugs on conduit artery endothelial function. [2003.06]
Other research related to Micardis HCT (Telmisartan / Hydrochlorothiazide)
Telmisartan/Hydrochlorothiazide combination therapy for the treatment of
hypertension: a pooled analysis in older and younger patients. [2013]
Efficacy and tolerability of a single-pill combination of
telmisartan/hydrochlorothiazide 80/25 mg in Chinese and Korean patients with
moderate to severe hypertension: a subgroup analysis of a randomized,
double-blind, active-controlled trial. [2013]
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide. [2010.12]
Significant hyperkalemia and hyponatremia secondary to telmisartan/hydrochlorothiazide treatment. [2010.12]
Fixed-dose telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and improving endothelial dysfunction in hypertensive patients. [2010.07]
Fixed-dose telmisartan/hydrochlorothiazide in comparison with
losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and
improving endothelial dysfunction in hypertensive patients. [2010]
Treatment of hypertension: postmarketing surveillance study results of telmisartan monotherapy, fixed dose combination of telmisartan + hydrochlorothiazide/amlodipine. [2009.10]
Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study. [2007.10.02]
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension? [2007]
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. [2005.11.24]
Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: Pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. [2005.11]
Telmisartan/hydrochlorothiazide: a new fixed dose combination. [2005.05]
Pre-clinical and clinical experience of telmisartan in cardiac remodelling. [2005]
Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension. [2004.11]
Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension. [2004.09]
[Kinzalkomb, a fixed telmisartan-hydrochlorothiazide combination for the treatment of hypertension] [2003.09]
Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension. [2003]
A new fixed-dose combination for added blood pressure control: telmisartan plus hydrochlorothiazide. [2002.07]
Long-term exposure to telmisartan as monotherapy or combination therapy: efficacy and safety. [2002]
Telmisartan: a review of its use in hypertension. [2001]
Other possibly related research studies
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting. [2006.01]
Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers. [2005.05]
Gateways to clinical trials. [2005.03]
Gateways to clinical trials. [2004.09]
Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies. [2004.10]
Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states? [2003.11]
Gateways to clinical trials. [2002.05]
Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension. [2000.04]
Gateways to clinical trials. [2006.10]
Gateways to clinical trials. [2007.10]
Gateways to clinical trials. [2008.01]
Warfarin and bosentan interaction in a patient with pulmonary hypertension secondary to bilateral pulmonary emboli. [2010.01]
Gateways to clinical trials. [2010.09]
|